January 21, 2014

Durham's Argos Therapeutics looking to raise up to $60 million with IPO

Argos Therapeutics is hoping that Wall Street will value its business in the neighborhood of $250 million. The Durham drug-development company provided more details Tuesday in its latest filing with the Securities and Exchange Commission.

Related content